Table 4

Clinical outcomes after PCC administration (haemostasis and survival)

Indication

Haemostasis

Survival

Complete

Partial

Not achieved

Not recorded

Death not related to bleeding

Death related to bleeding

Alive after episode

Cardiac surgery (CABG; n = 5)

2 (40%)

2 (40%)

0 (0%)

1 (20%)

2 (40%)

1 (20%)

2 (40%)

Cardiac surgery (valve replacement; n = 2)

0 (0%)

2 (100%)

0 (0%)

0 (0%)

1 (50%)

0 (0%)

1 (50%)

Other surgery (n = 9)

1 (11.1%)

5 (55.6%)

1 (11.1%)

2 (22.2%)

4 (44.4%)

2 (22.2%)

3 (33.3%)

Warfarin reversal (n = 8)

2 (25%)

0 (0%)

3 (37.5%)

3 (37.5%)

1 (12.5%)

1 (12.5%)

6 (75%)

All patients (n = 24)

5 (20.8%)

9 (37.5%)

4 (16.7%)

6 (25.0%)

8 (33.3%)

4 (16.6%)

12 (50%)

All values are presented as n (%). CABG, coronary artery bypass graft; PCC, prothrombin complex concentrate.

Bruce and Nokes Critical Care 2008 12:R105   doi:10.1186/cc6987